Sword

For most of history, access to high-quality healthcare has been a privilege of circumstance. Changing that takes bravery. That's why we partnered with Monocle to publish 𝘛𝘩𝘦 𝘍𝘶𝘵𝘶𝘳𝘦 𝘰𝘧 𝘏𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦. Inside this limited-edition hardcover, world leaders, industry pioneers, and visionary clinicians share their boldest ideas for the road ahead, including essays and interviews from Patrick Conway, the CEO of Optum, Penny Dash, the Chair of NHS England, Marjorie Michel, Canada’s Health Minister, Vinod Khosla from Khosla Ventures, Chris Bischoff from General Catalyst, alongside our very own CEO Virgílio (“V”) Bento, and many more. Don’t just watch this movement from the sidelines, lead it. Request your copy now: https://lnkd.in/eMYf3HEr

Every era has a problem big enough to demand the very best of human ingenuity. In 1962, it was the original moonshot. Today, it's healthcare. AI has made a fundamentally new model of healthcare possible. Delivering it is going to take the kind of speed and coordination we haven't seen since the space race. Today, we’re laying out our vision in full, alongside the safety considerations and coordination it will take to get there. This is not something we can build alone. It will require the best of us, together. Join us. Link to the full manifesto in the comments.

Get the latest jobs and industry news

Are your GLP-1 and cardiometabolic vendors actually delivering value? Join Abinue Fortingo, who leads Brown & Brown’s large-market Population Health consulting team, and Sword Health’s Kevin and Amanda for a working session on how to evaluate clinical impact, vendor value, and potential overlap across your cardiometabolic strategy. September 28 | 12:00 ET

For companies like your organization, healthcare costs are projected to rise 8.2% in 2027, the steepest increase since 2003, with GLP-1 utilization accounting for a full percentage point of that growth. On September 28, Brown & Brown’s Abinue Fortingo and Sword Health’s Kevin and Amanda will break down how to evaluate vendor pricing, guarantees, and clinical impact, so you can understand where the spend is delivering value. One hour. Practical framework. Live Q&A.

The GLP-1 and cardiometabolic vendor landscape is getting harder to compare. On September 28, Brown & Brown’s Abinue Fortingo and Sword Health’s Kevin and Amanda, will share a practical framework for evaluating clinical impact, integration, pricing, and guarantees — so you can make recommendations you can stand behind. September 28 | 12:00 ET